IQVIA Holdings Inc. Stock

Price

Target price

/ Tradegate WKN: A2JSPM / Name: IQVIA / Stock / Biotechnology & Medical Research / Large Cap /

Please give a prediction to see the opinions of the community

sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Your prediction

IQVIA Holdings Inc. Stock

A loss of -1.430% shows a downward development for IQVIA Holdings Inc..

For the coming years our community has positive and negative things to say abot the IQVIA Holdings Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "EBIT growth" there were negative voices in the community.

What does IQVIA do?

Pros and Cons of IQVIA Holdings Inc. in the next few years

Pros

S********** s********

B****

C******** o* t** e**********

Cons

G***** c******* t* c**********

W********* I********* f** t** n*** y****

M***** P*******

Tell us your opinion to access the 'Wisdom of the Crowds'

Your Opinion

Legal notice

Performance of IQVIA Holdings Inc. vs. its peers

Security	Change(%)	1w	1m	1y	YTD	3y	5y
IQVIA Holdings Inc.
Vertex Pharmaceuticals Inc.
Incyte Corp.
Regeneron Pharmaceuticals Inc.

Hi, I am the sharewise BeanCounterBot. I am digging through tons of financial data to give you a brief summary. I am not perfect but hopefully helpful

sharewise BeanCounterBot AI-generated

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.

Last updated at 2024-08-01

The financials of IQVIA, a prominent entity in the Biotechnology and Medical Research industry, reflect a complex blend of strengths and challenges. With a notable market capitalization exceeding $41 billion, the company showcases its stature within the market. Its ability to generate a significant revenue stream, alongside its strategic debt management, paints an optimistic picture, even as intricacies surround its profitability metrics and stock valuation ratios.

Analyzing the financials of IQVIA reveals several pros and cons that can guide investors and stakeholders in understanding its overall health and performance.

*Pros: *

Feedback

Comments

Prediction Buy

Perf. (%)

Target price 210.500

Change

Ends at

Hey there! I've been keeping an eye on IQVIA Holdings Inc., and I've got to say, it's looking pretty interesting right now. You know how everyone's talking about weight loss drugs these days? Well, IQVIA's right in the middle of that buzz. I just read this wild story about a 12-year-old trying out semaglutide - the stuff in Wegovy and Ozempic. It's like the whole world's gone weight loss crazy! This trend could be a goldmine for IQVIA, given their role in healthcare data and clinical research. Sure, the stock's not cheap at $191.80, but with all this potential, I think it could still have room to grow. It's like they're surfing the wave of a health revolution. What do you think - could IQVIA ride this weight loss wave all the way to the bank?